Education
About Us
Working with TipRanks
Follow Us
BioStem Technologies Inc (BSEM)
OTHER OTC:BSEM
BSEM Stock Chart & Stats
$4.87
$0.88(5.85%)
At close: 4:00 PM EST
$4.87
$0.88(5.85%)
Day’s Range― - ―
52-Week Range$4.07 - $28.26
Previous CloseN/A
Volume47.30K
Average Volume (3M)67.46K
Market Cap
$79.57M
Enterprise Value$187.45M
Total Cash (Recent Filing)$22.83M
Total Debt (Recent Filing)$4.39M
Price to Earnings (P/E)4.3
Beta1.74
Next Earnings
Nov 18, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding16,338,436
10 Day Avg. Volume51,947
30 Day Avg. Volume67,460
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)5.54
Price to Sales (P/S)0.75
P/FCF Ratio9.42
Enterprise Value/Market Cap2.36
Enterprise Value/Revenue0.62
Enterprise Value/Gross Profit0.65
Enterprise Value/Ebitda5.96
Forecast
1Y Price Target
$8.00Price Target Upside64.27% Upside
Rating ConsensusHold
Number of Analyst Covering0
BioStem Technologies News
BSEM FAQ
What was BioStem Technologies Inc’s price range in the past 12 months?
BioStem Technologies Inc lowest stock price was $4.07 and its highest was $28.26 in the past 12 months.
What is BioStem Technologies Inc’s market cap?
BioStem Technologies Inc’s market cap is $79.57M.
When is BioStem Technologies Inc’s upcoming earnings report date?
BioStem Technologies Inc’s upcoming earnings report date is Nov 18, 2025 which is in 29 days.
How were BioStem Technologies Inc’s earnings last quarter?
BioStem Technologies Inc released its earnings results on Aug 14, 2025. The company reported -$0.03 earnings per share for the quarter, missing the consensus estimate of $0.32 by -$0.35.
Is BioStem Technologies Inc overvalued?
According to Wall Street analysts BioStem Technologies Inc’s price is currently Undervalued.
Does BioStem Technologies Inc pay dividends?
BioStem Technologies Inc does not currently pay dividends.
What is BioStem Technologies Inc’s EPS estimate?
BioStem Technologies Inc’s EPS estimate is 0.
How many shares outstanding does BioStem Technologies Inc have?
BioStem Technologies Inc has 16,338,436 shares outstanding.
What happened to BioStem Technologies Inc’s price movement after its last earnings report?
BioStem Technologies Inc reported an EPS of -$0.03 in its last earnings report, missing expectations of $0.32. Following the earnings report the stock price went down -32.177%.
Which hedge fund is a major shareholder of BioStem Technologies Inc?
Currently, no hedge funds are holding shares in BSEM
BioStem Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.00 (64.27% Upside)
$8.00 (64.27% Upside)
Blogger Sentiment
Bullish
BSEM Sentiment 100%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 0.3%
Last 30 Days ▼ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.00%
12-Months-Change
Fundamentals
Return on Equity
82.80%
Trailing 12-Months
Asset Growth
23.50%
Trailing 12-Months
Company Description
BioStem Technologies Inc
BioStem Technologies (BSEM) is a biotechnology company focused on advancing the field of regenerative medicine through the development and commercialization of innovative cellular therapies. Operating primarily in the healthcare sector, BioStem leverages its proprietary technology to extract, process, and deliver stem cell-based products for various medical applications, including orthopedic, wound care, and aesthetic treatments. The company aims to improve patient outcomes by offering advanced solutions derived from human placental tissue and other cellular sources.
BSEM Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
While BioStem continues to show operational and clinical progress with positive EBITDA and strategic growth plans, the significant revenue decline and reimbursement uncertainties present notable challenges. The sentiment is mixed, with strong financial metrics and future potential counterbalanced by current market and competitive pressures.View all BSEM earnings summariesTechnical Analysis
Crescent Biopharma
―
Voyager Therapeutics
―
Diamedica Therapeutics
―
Black Diamond Therapeutics
―
Innate Pharma
―